Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
martedì, ottobre 20
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Tyra Biosciences Inc
TYRA
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$19.34
0.82
4.43%
Ult. Agg.: Oct 20, 7:15 AM
$19.65
1.13
6.1%
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Privacy Manager
Tyra Biosciences Financials
Tyra Biosciences (TYRA) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Stock Market Today: S&P 500, Dow and Nasdaq Futures Fall as Brent Hovers Near $107 and FOMC Commences Two-Day Meeting— MSTR, CRWD, BMM in Focus (UPDATED)
U.S. stock futures declined on Tuesday, as the Dow Jones, S&P 500 and Nasdaq 100 indices fell, following Monday's lower close.
Rishabh Mishra
Crude Oil Jumps 3%; Corning Shares Move Lower
U.S. stocks fell Monday as tech slid; Nvidia may invest $10B in Anthropic’s IPO. Oil rose 3%, while gold, silver and copper declined.
Avi Kapoor
PRO
Tyra Biosciences Q2 EPS $(0.69) Misses $(0.65) Estimate
Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.65) by 6.15 percent. This is a 46.81 percent decrease over losses of $(0.47) per share
Benzinga Newsdesk
PRO
Tyra Biosciences Q1 EPS $(0.64) Misses $(0.59) Estimate
Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.59) by 8.47 percent. This is a 36.17 percent decrease over losses of $(0.47) per share from
Benzinga Newsdesk
PRO
Tyra Biosciences Q4 EPS $(0.57) Misses $(0.55) Estimate
Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.55) by 4.2 percent. This is a 32.56 percent decrease over losses of $(0.43) per share from
Benzinga Newsdesk
PRO
Tyra Biosciences Q3 EPS $(0.50), Inline
Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.50) per share which met the analyst consensus estimate. This is a 21.95 percent decrease over losses of $(0.41) per share from the same period last year.
Benzinga Newsdesk
